Teva donates potential coronavirus treatment to hospitals across the US
Hydroxychloroquine sulfate tablets are used against malaria, lupus erythematosus and rheumatoid arthritis but could be effective against COVID-19.
A building belonging to generic drug producer Teva, Israel's largest company with a market value of about $57 billion, is seen in Jerusalem(photo credit: REUTERS/BAZ RATNER)ByJERUSALEM POST STAFF
